Express Scripts Indication-Based Contracts For Inflammatory Drugs Begin In 2017

Program may provide drugs with narrower labels an opportunity to gain preferred formulary status versus entrenched market leaders.

Express Scripts HQ

Indication-specific pricing may begin to reshape US reimbursement for anti-inflammatory drugs in the first half of 2017, when pharmacy benefit manager Express Scripts Holding Co. launches its new approach to contracting.

In a move away from paying for anti-inflammatory drugs as a broad category, Express Scripts will negotiate separate pricing for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet